{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:02:55Z","timestamp":1780030975030,"version":"3.53.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA042110"],"award-info":[{"award-number":["DA042110"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110653","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T14:58:12Z","timestamp":1755961092000},"page":"110653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hypocretin signaling in the central amygdala drives methamphetamine self-administration in male rats"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0353-1192","authenticated-orcid":false,"given":"Tyler A.","family":"Zarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9857-4493","authenticated-orcid":false,"given":"George F.","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4328-5339","authenticated-orcid":false,"given":"Brooke E.","family":"Schmeichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110653_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.282.5387.298","article-title":"Transition from moderate to excessive drug intake: change in hedonic set point","volume":"282","author":"Ahmed","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110653_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/adb.12629","article-title":"Revisiting long-access versus short-access cocaine self-administration in rats: intermittent intake promotes addiction symptoms independent of session length","volume":"24","author":"Allain","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110653_bib3","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3389\/fpsyg.2019.02564","article-title":"The effect of high-intensity interval\/circuit training on cognitive functioning and quality of life during recovery from substance abuse disorder. A study protocol","volume":"0","author":"Andreassen","year":"2019","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110653_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bph.12639","article-title":"Orexin\/hypocretin role in reward: implications for opioid and other addictions","volume":"172","author":"Baimel","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110653_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/cne.10783","article-title":"Overlapping distributions of orexin\/hypocretin- and dopamine-\u03b2-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress","volume":"464","author":"Baldo","year":"2003","journal-title":"J. Comp. Neurol."},{"issue":"52","key":"10.1016\/j.neuropharm.2025.110653_bib6","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.0507480102","article-title":"Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior","volume":"102","author":"Boutrel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2025.110653_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.psychres.2016.02.059","article-title":"Orexin-A level elevation in recently abstinent male methamphetamine abusers","volume":"239","author":"Chen","year":"2016","journal-title":"Psychiatry Res."},{"issue":"19","key":"10.1016\/j.neuropharm.2025.110653_bib8","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.21-19-j0003.2001","article-title":"Orexin (Hypocretin) neurons contain dynorphin","volume":"21","author":"Chou","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110653_bib9","author":"Cope"},{"key":"10.1016\/j.neuropharm.2025.110653_bib10","series-title":"The Professional Protection Officer: Practical Security Strategies and Emerging Trends","first-page":"233","article-title":"Substance abuse","author":"Daley","year":"2019"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110653_bib11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin\u2013orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espa\u00f1a","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110653_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/psyrad\/kkac021","article-title":"Neurobiological mechanisms and related clinical treatment of addiction: a review","volume":"2","author":"Fang","year":"2022","journal-title":"Psychoradiology"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110653_bib14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/npp.2017.158","article-title":"Effects of suvorexant, a dual orexin\/hypocretin receptor antagonist, on impulsive behavior associated with cocaine","volume":"43","author":"Gentile","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110653_bib15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.biopsych.2011.02.004","article-title":"Neuropeptide y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence","volume":"69","author":"Gilpin","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110653_bib16","author":"Harris"},{"key":"10.1016\/j.neuropharm.2025.110653_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/FBP.0b013e328343d761","article-title":"Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward","volume":"22","author":"Hutcheson","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110653_bib18","first-page":"1","volume":"329","author":"Ingram","year":"2018"},{"key":"10.1016\/j.neuropharm.2025.110653_bib19","article-title":"Increased number and activity of a lateral subpopulation of hypothalamic orexin\/hypocretin neurons underlies the expression of an addicted state in rats","author":"James","year":"2018","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110653_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nm.2075","article-title":"A key role for orexin in panic anxiety","volume":"16","author":"Johnson","year":"2009","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110653_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.15585\/mmwr.mm6912a1","article-title":"Patterns and characteristics of methamphetamine use among adults \u2014 united States, 2015\u20132018","volume":"69","author":"Jones","year":"2020","journal-title":"MMW Morbidity Mortal. Week. Rep."},{"key":"10.1016\/j.neuropharm.2025.110653_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113306","article-title":"Choose your path: divergent basolateral amygdala efferents differentially mediate incentive motivation, flexibility and decision-making","volume":"409","author":"Keefer","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"24","key":"10.1016\/j.neuropharm.2025.110653_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/adaw.32751","article-title":"NIDA: plethora of treatments for SUDs, regardless of substance","volume":"32","author":"Knopf","year":"2020","journal-title":"Alcohol Drug Abuse Wkly."},{"key":"10.1016\/j.neuropharm.2025.110653_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2009.03.038","article-title":"Brain stress systems in the amygdala and addiction","volume":"1293","author":"Koob","year":"2009","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110653_bib25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.conb.2013.03.011","article-title":"Negative reinforcement in drug addiction: the darkness within","volume":"23","author":"Koob","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110653_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.biopsych.2020.11.008","article-title":"A basolateral amygdala microcircuit for drug craving: is there a craving engram?","volume":"89","author":"Koob","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"PART B","key":"10.1016\/j.neuropharm.2025.110653_bib27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neuropharm.2013.05.024","article-title":"Addiction as a stress surfeit disorder","volume":"76","author":"Koob","year":"2014","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110653_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110653_bib29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.bjp.0706789","article-title":"The orexin system regulates alcohol-seeking in rats","volume":"148","author":"Lawrence","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110653_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41386-022-01417-y","article-title":"Modulation of methamphetamine memory reconsolidation by neural projection from basolateral amygdala to nucleus accumbens","volume":"48","author":"Li","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110653_bib31","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health","author":"Lipari","year":"2020"},{"key":"10.1016\/j.neuropharm.2025.110653_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nn.3664","article-title":"Designer receptors show role for ventral pallidum input to ventral tegmental area in cocaine seeking","volume":"17","author":"Mahler","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110653_bib66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.116.235945","article-title":"Orexin-A\/Hypcretin-1 mediates cocaine-seeking behavior in the posterior paraventricular nucleus of the thalamus via orexin\/hypocretin receptor-2","volume":"359","author":"Matzeu","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"AUG","key":"10.1016\/j.neuropharm.2025.110653_bib33","article-title":"Drug seeking and relapse: new evidence of a role for orexin and dynorphin Co-transmission in the paraventricular nucleus of the thalamus","volume":"9","author":"Matzeu","year":"2018","journal-title":"Front. Neurol."},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110653_bib35","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"Mclellan","year":"2000","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.neuropharm.2025.110653_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1315542111","article-title":"Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area","volume":"111","author":"Muschamp","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110653_bib38","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1360-0443.2007.02011.x","article-title":"Self-administration of drugs in animals and humans as a model and an investigative tool","volume":"102","author":"Panlilio","year":"2007","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110653_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002722","article-title":"Ventral hippocampus to nucleus accumbens shell circuit regulates approach decisions during motivational conflict","volume":"23","author":"Patterson","year":"2025","journal-title":"PLoS Biol."},{"issue":"23","key":"10.1016\/j.neuropharm.2025.110653_bib40","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110653_bib41","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/npp.2011.315","article-title":"Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration","volume":"37","author":"Recinto","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110653_bib42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00213-012-2727-8","article-title":"Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats","volume":"223","author":"Reichel","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110653_bib43","first-page":"1","volume":"66","author":"Richardson","year":"1996"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110653_bib44","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.biopsych.2009.11.007","article-title":"Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence","volume":"67","author":"Roberto","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110653_bib45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"49","key":"10.1016\/j.neuropharm.2025.110653_bib47","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1979-13.2013","article-title":"Long-term antagonism of \u03ba opioid receptors prevents escalation of and increased motivation for heroin intake","volume":"33","author":"Schlosburg","year":"2013","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110653_bib48","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.biopsych.2016.06.010","article-title":"Hypocretin neurotransmission within the central amygdala mediates escalated cocaine self-administration and stress-induced reinstatement in rats","volume":"81","author":"Schmeichel","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110653_bib49","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/s41386-018-0054-4","article-title":"Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats","volume":"43","author":"Schmeichel","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110653_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.814574","article-title":"Modeling stimulant and opioid Co-use in rats provided concurrent access to methamphetamine and fentanyl","volume":"13","author":"Seaman","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110653_bib51","first-page":"137","article-title":"DREADDs: use and application in behavioral neuroscience","volume":"130","author":"Smith","year":"2016"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110653_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1460-9568.2009.06844.x","article-title":"Orexin\/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking","volume":"30","author":"Smith","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110653_bib53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2005.03.002","article-title":"Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior","volume":"1044","author":"Suzuki","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110653_bib54","series-title":"Current Protocols in Neuroscience\/Editorial Board","first-page":"1","article-title":"Chronic intravenous drug self-administration in rats and mice","author":"Thomsen","year":"2005"},{"key":"10.1016\/j.neuropharm.2025.110653_bib55","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuropharm.2017.12.006","article-title":"Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats","volume":"131","author":"Tunstall","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110653_bib56","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neuron.2017.09.024","article-title":"The anterior Insular cortex\u2192Central amygdala glutamatergic pathway is critical to relapse after contingency management","volume":"96","author":"Venniro","year":"2017","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110653_bib57","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110653_bib58","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1124\/jpet.106.113340","article-title":"Effects of dose and session duration on cocaine self-administration in rats","volume":"320","author":"Wee","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110653_bib59","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/sj.npp.1301353","article-title":"Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration","volume":"32","author":"Wee","year":"2007","journal-title":"Neuropsychopharmacology: Off. Publ. Am College Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110653_bib60","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1523\/JNEUROSCI.1978-13.2015","article-title":"\u03ba opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake","volume":"35","author":"Whitfield","year":"2015","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110653_bib61","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/appi.ajp.2008.07121877","article-title":"Amygdala volume associated with alcohol abuse relapse and craving","volume":"165","author":"Wrase","year":"2008","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110653_bib62","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1471-4159.2007.04748.x","article-title":"Long-lasting up-regulation of orexin receptor type 2 protein levels in the rat nucleus accumbens after chronic cocaine administration","volume":"103","author":"Zhang","year":"2007","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110653_bib63","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.111.187567","article-title":"Orexin-1 receptor mediation of cocaine seeking in male and female rats","volume":"340","author":"Zhou","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110653_bib64","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.neuropharm.2012.07.044","article-title":"Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats","volume":"63","author":"Zhou","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110653_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108719","article-title":"Age-specific treatment effects of orexin\/hypocretin-receptor antagonism on methamphetamine-seeking behavior","volume":"224","author":"Zlebnik","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110653_bib67","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1369-1600.2011.00329.x","article-title":"Extended access cocaine self\u2010administration differentially activates dorsal raphe and amygdala corticotropin\u2010releasing factor systems in rats","volume":"17","author":"Zorrilla","year":"2012","journal-title":"Addict. Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:19:41Z","timestamp":1780028381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":63,"alternative-id":["S0028390825003612"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110653","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypocretin signaling in the central amygdala drives methamphetamine self-administration in male rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110653"}}